Related Experiment Videos
Allergic contact dermatitis to cinchocaine.
1Skin and Cancer Foundation, Melbourne, Victoria, Australia. chriskearney@hotmail.com
The Australasian Journal of Dermatology
|April 20, 2001
Summary
Allergic contact dermatitis to cinchocaine highlights issues with topical anesthetic classification and cross-reactivity. Benzocaine is insufficient for screening topical anesthetic contact allergy.
Area of Science:
- Dermatology
- Allergology
- Pharmacology
Background:
- Topical anesthetic agents are widely used for symptomatic relief.
- Classification and cross-reactivity patterns among these agents can be complex.
- Accurate diagnosis of allergic contact dermatitis is crucial for patient management.
Observation:
- A patient presented with acute perianal dermatitis after using Proctosedyl ointment.
- The dermatitis was suspected to be allergic contact dermatitis.
- Patch testing was performed to identify the causative agent.
Findings:
- The patient exhibited allergic contact dermatitis to cinchocaine, an ingredient in Proctosedyl ointment.
- Positive reactions were observed to cinchocaine and the Proctosedyl ointment itself.
- No allergic reaction was noted to benzocaine or lignocaine during patch testing.
Implications:
- This case underscores the diagnostic challenges in topical anesthetic allergy.
- It questions the adequacy of benzocaine as a sole screening agent for contact allergy to topical anesthetics.
- Further research into cross-reactivity patterns among topical anesthetics is warranted.